Policy & Regulation
India Rewrites the Rulebook for Stem Cell Therapies and Essential Drug Pricing in Landmark Healthcare Reform
New regulatory framework brings gene and cell therapies under formal oversight while controversial pricing changes could reshape access to essential medicines
HealthAI Central Editorial Team·July 3, 2026
Clinical AI
Cancer's Escape Route: How Tumors Outsmart Billion-Dollar Blood Vessel Drugs
KAIST researchers reveal the molecular mechanism behind anti-VEGF therapy resistance, pointing toward AI-driven combination treatments that could finally stop cancer's vascular hijacking.
HealthAI Central Editorial Team·July 3, 2026
Clinical AI
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.
HealthAI Central Editorial Team·June 16, 2026